Tom Powles (@tompowles1) 's Twitter Profile
Tom Powles

@tompowles1

Interested in Urology Cancers, biomarkers and drug development.

ID: 1206580727296544769

calendar_today16-12-2019 14:24:22

1,1K Tweet

12,12K Takipçi

62 Takip Edilen

Tom Powles (@tompowles1) 's Twitter Profile Photo
Tom Powles
@tompowles1

a year ago

Updated clear cell renal cancer guidlines ESMO - Eur. Oncology.Ipi/nivo now has additional weak support in IMDC good risk (I,C). Belzutifan gets strong support in 3rd line (I,B) but less strong 2nd line (VEGF TKI preferred).1st line PD1/VEGF unchanged Annals of Oncology ow.ly/nZA050RP77l

Updated clear cell renal cancer guidlines <a href="/myESMO/">ESMO - Eur. Oncology</a>.Ipi/nivo now has additional weak support in IMDC good risk (I,C). Belzutifan gets strong support in 3rd line (I,B) but less strong 2nd line (VEGF TKI preferred).1st line PD1/VEGF unchanged <a href="/Annals_Oncology/">Annals of Oncology</a> ow.ly/nZA050RP77l